RGGI yields 2000000.00% · JNJ yields 2.13%● Live data
📍 RGGI pulled ahead of the other in Year 1
Combined, RGGI + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RGGI + JNJ for your $10,000?
Resgreen Group International Inc. primarily engages in the acquisition, exploration, and development of uranium mining properties in Africa. The company holds an option to acquire up to a 100% undivided right, title, and interest in and to the Gambaro Resources property located in Njombe and Songea districts in the Republic of Tanzania. It also has option to acquire up to a 75% undivided right, title, and interest in and to the Nkoko and Kagadi uranium properties, which contain approximately 820 square kilometers located in Kiballe District, Uganda; and option to earn a 75% interest in the Karoo project that consists of approximately 8,600 square kilometers of Karoo-based uranium exploration lands located in the Southern regions of Tanzania. The company was formerly known as Uranium Hunter Corporation and changed its name to Resgreen Group International Inc. in February 2007. Resgreen Group International Inc. was founded in 2003 and is based in Toronto, Canada.
Full RGGI Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.